Clarify Health

NOVEMBER 22, 2023

This increase can be attributed to many things, including an aging population, the increasing prevalence of chronic conditions, and greater access to care stemming from expanded insurance coverage. With higher price tags, the incentive for quality improvement is lower, setting back efforts to drive value-based care.

Leads 52

Leads Healthcare Healthcare Patients 52

pharmaphorum

NOVEMBER 16, 2022

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations. The model for making a profit from medicine is geared towards delivering medicines regularly, usually for chronic conditions.

Medicine 123

Medicine Marketing Healthcare Healthcare 123

European Pharmaceutical Review

MAY 11, 2023

Three SMN-enhancing treatments for the condition are approved by the US Food and Drug Administration (FDA) 2 , however there is no cure for SMA at present. What are the challenges in treating conditions such as spinal muscular atrophy? 1 This is assuming a $1M price tag for all gene therapies.

Food and Drug Administration 71

Food and Drug Administration Government Healthcare Healthcare 71

PM360

SEPTEMBER 7, 2023

We also put big pull tags on the little pouches that held the items. HS is a chronic and debilitating inflammatory skin disease where recurrent boil-like lumps form under the skin and can break open causing abscesses, drainage, and sores, taking both a physical and psychological toll on patients.

Patients 105

Patients Pharma Education Doctors 105

Healthcare Success

NOVEMBER 14, 2022

There are three main reasons for this: The United States has a large aging population and a long history of chronic disease. Once you have your primary keywords or phrases selected, be sure they are included in the following areas: Title tags Meta description tags Heading tags Body copy. billion in 2022 to 964.90

Medical 69

Medical Marketing Engineering Doctors 69

PM360

APRIL 7, 2023

The shift toward longer, more adequate timeframes to establish proof of concept can be as long as three to four years, 1 given the complex requirements for developing and launching specialty drugs and cell and gene therapies (CGTs) for individuals with complex conditions or rare or orphan diseases.

Manufacturing 52

Manufacturing Marketing Patients Safety 52

Cadensee

JANUARY 1, 2022

And that really shifted a lot of the modalities including preventive care and urgent care, of course, primary care and even chronic care, much more to the front stage. It's already tagged by clinicians with the diagnosis, so you have to do the machine learning and the engineering side. So, not only the urgent care as it used to be.

Marketing 52

Marketing Physicians Medical Healthcare 52